(Q44849781)

6 December 2017

A nationwide survey of deep fungal infections and fungal prophylaxis after hematopoietic stem cell transplantation in Japan (English)

1 reference

6 December 2017

Imataki O

1

1 reference

6 December 2017

Kami M

2

1 reference

6 December 2017

Kim SW

3

1 reference

6 December 2017

Gotoh M

4

1 reference

6 December 2017

Komaba S

5

1 reference

6 December 2017

Kasai M

6

1 reference

6 December 2017

Hashino S

7

1 reference

6 December 2017

Naito K

8

1 reference

6 December 2017

Masuda M

9

1 reference

6 December 2017

Anan K

10

1 reference

6 December 2017

Teshima H

11

1 reference

6 December 2017

Togitani K

12

1 reference

6 December 2017

Inoue T

13

1 reference

6 December 2017

Nishimura M

14

1 reference

6 December 2017

Adachi Y

15

1 reference

6 December 2017

Fukuhara T

16

1 reference

6 December 2017

Yamashita T

17

1 reference

6 December 2017

Uike N

18

1 reference

6 December 2017

Kobayashi Y

19

1 reference

6 December 2017

Hamaguchi M

20

1 reference

6 December 2017

Higuchi M

21

1 reference

6 December 2017

Kawakami K

22

1 reference

6 December 2017

Takaue Y

23

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

Bone Marrow Transplantation

6 December 2017

1 reference

6 December 2017

33

1 reference

6 December 2017

12

1 reference

6 December 2017

1173-1179

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704526

6 December 2017

0 references

cites work

Fungal infections after bone marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Developing a pediatric outpatient transplantation program. The Children's Memorial Hospital experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Serum levels of fluconazole in patients after cytotoxic chemotherapy for hematological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

7 January 2021

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

7 January 2021

Plasma concentration of itraconazole in patients receiving chemotherapy for hematological malignancies: the effect of famotidine on the absorption of itraconazole

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

7 January 2021

Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

7 January 2021

Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704526

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704526

1 reference

6 December 2017

1 reference